Axon Enterprise, Inc $AXON Shares Purchased by 180 Wealth Advisors LLC

180 Wealth Advisors LLC boosted its position in Axon Enterprise, Inc (NASDAQ:AXON) by 35.2% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 519 shares of the biotechnology company’s stock after acquiring an additional 135 shares during the quarter. 180 Wealth Advisors LLC’s holdings in Axon Enterprise were worth $430,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in the company. LaSalle St. Investment Advisors LLC raised its holdings in Axon Enterprise by 2.1% in the first quarter. LaSalle St. Investment Advisors LLC now owns 777 shares of the biotechnology company’s stock valued at $408,000 after acquiring an additional 16 shares in the last quarter. Hemington Wealth Management raised its holdings in Axon Enterprise by 70.8% in the second quarter. Hemington Wealth Management now owns 41 shares of the biotechnology company’s stock valued at $33,000 after acquiring an additional 17 shares in the last quarter. Smartleaf Asset Management LLC raised its holdings in Axon Enterprise by 5.0% in the first quarter. Smartleaf Asset Management LLC now owns 379 shares of the biotechnology company’s stock valued at $203,000 after acquiring an additional 18 shares in the last quarter. WCM Investment Management LLC raised its holdings in Axon Enterprise by 0.8% in the first quarter. WCM Investment Management LLC now owns 2,441 shares of the biotechnology company’s stock valued at $1,306,000 after acquiring an additional 19 shares in the last quarter. Finally, Sheaff Brock Investment Advisors LLC raised its holdings in Axon Enterprise by 0.5% in the first quarter. Sheaff Brock Investment Advisors LLC now owns 3,561 shares of the biotechnology company’s stock valued at $1,873,000 after acquiring an additional 19 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insiders Place Their Bets

In other news, insider Jeffrey C. Kunins sold 7,891 shares of Axon Enterprise stock in a transaction on Thursday, August 14th. The shares were sold at an average price of $750.10, for a total value of $5,919,039.10. Following the transaction, the insider directly owned 144,538 shares of the company’s stock, valued at $108,417,953.80. The trade was a 5.18% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, President Joshua Isner sold 15,919 shares of Axon Enterprise stock in a transaction on Friday, August 15th. The shares were sold at an average price of $746.26, for a total transaction of $11,879,712.94. Following the completion of the transaction, the president directly owned 238,379 shares in the company, valued at $177,892,712.54. The trade was a 6.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 59,932 shares of company stock worth $45,115,616. Corporate insiders own 4.40% of the company’s stock.

Axon Enterprise Stock Performance

Shares of Axon Enterprise stock opened at $735.95 on Friday. The firm’s fifty day simple moving average is $733.17 and its 200-day simple moving average is $725.28. The stock has a market capitalization of $57.77 billion, a price-to-earnings ratio of 181.72, a PEG ratio of 28.58 and a beta of 1.41. Axon Enterprise, Inc has a 12 month low of $422.38 and a 12 month high of $885.91. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.95 and a quick ratio of 2.71.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, beating analysts’ consensus estimates of $1.54 by $0.58. The business had revenue of $668.54 million for the quarter, compared to analysts’ expectations of $641.77 million. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The company’s quarterly revenue was up 32.6% on a year-over-year basis. During the same period in the previous year, the company posted $1.20 EPS. Axon Enterprise has set its FY 2025 guidance at EPS. As a group, equities analysts forecast that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of analysts have weighed in on AXON shares. Needham & Company LLC reissued a “buy” rating and set a $870.00 price objective on shares of Axon Enterprise in a report on Wednesday, September 24th. Zacks Research cut shares of Axon Enterprise from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 2nd. JMP Securities reissued a “market outperform” rating and set a $825.00 price objective on shares of Axon Enterprise in a report on Monday, September 29th. Northland Securities set a $800.00 price objective on shares of Axon Enterprise in a report on Tuesday, August 5th. Finally, Wolfe Research started coverage on shares of Axon Enterprise in a report on Monday, July 7th. They set an “outperform” rating on the stock. Fourteen investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $841.64.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.